Share This Page

Alzheimer's And Dementia Weekly

Support & Insight for the Autumn of Life

Drugs:Dementia

Leqembi Becomes Europe’s First Alzheimer’s Antibody

April 16, 2025 No Comments

The European Union authorizes Leqembi as its very first Alzheimer’s drug to target an underlying cause of Alzheimer’s.

Study authors David Gate (left) and Lynn van Olst (right) compare two slides containing human brain tissue. Brown amyloid beta plaques are visible in the left slide, which contains brain tissue with Alzheimer's Disease that had not been treated. The slide on the right, which contains brain tissue that had been treated, does not show amyloid plaques.

Can the New Alzheimer’s Drugs Work Even Better?

March 10, 2025 No Comments

The new Alzheimer’s antibodies, Leqembi and Kisunla, work better on some people than others. A cutting-edge technique called spatial transcriptomics may help figure out how to make them work better for everybody.

Close-up of doctor writing prescription with medicines and stethoscope on desk.

Advantages of Namzaric for Dementia

February 20, 2025 5 Comments

ARTICLE + VIDEO INFOMMERCIAL: Namazaric for dementia comes in a convenient, extended-release capsule. It conveniently combines today’s 2 most popular drugs for Alzheimer’s. Learn about easy-to-manage Namazaric.

An infusion of antibody therapy for Alzheimer's. (Courtesy of WashU Medicine news release using Getty Images)

Leqembi & Kisunla: Extending Independent Living

February 16, 2025 1 Comment

A new analysis of the benefits of these Alzheimer’s treatments scores the days and ways patients succeed in living independently.

Leqembi: Europe Checks It’s Safety; U.S. Approves Monthly Doses

February 3, 2025 No Comments

The EMA has announced its schedule for reviewing the Alzheimer’s drug Leqembi (lecanemab) for use in Europe. Meanwhile, the U.S. FDA, which already approved the drug, is moving ahead with a new version that doses Leqembi in a better, more convenient fashion for those taking the drug over the long run.

woman in white shirt holding clear plastic iv bag

What’s Ahead for Alzheimer’s Drugs in 2025

January 12, 2025 No Comments

Learn about 2025’s newly approved or potential Alzheimer’s drugs. These include Leqembi, Kisunla, Remternetug, Semaglutide, Trontinemab and Bepranemab.

Alzheimer's Amyloid Plaques choking neurons

Is Leqembi Shrinking the Alzheimer’s or the Brain?

January 5, 2025 1 Comment

Leqembi and Kisunla are the new Alzheimer’s immunotherapies. A loss of brain volume associated with these immunotherapies may be caused by the removal of amyloid plaques, rather than the loss of neurons or brain tissue. A new study sheds light on what’s going on.

Science Director Discussing Lecanemab (Leqembi)

Why Did Europe Finally Choose Lecanemab for Alzheimer’s?

November 28, 2024 No Comments

Europe originally said Lecanemab (Brand-name Leqembi) was too risky to approve. Now they are recommending marketing it. Why the change of heart?

Person with dementia and partner on door step

Catching Up to America: Europe Recommends Leqembi® for Alzheimer’s

November 17, 2024 No Comments

The European Medicines Agency (EMA) recommended approving Leqembi® (generic lecanemab) for Alzheimer’s. Originally skeptics, learn how the “Clarity AD” trial helped change their mind.

Leqembi Autoinjector to Treat Alzheimer’s in Seconds, Not Hours

November 3, 2024 No Comments

Leqembi is an FDA-Approved Alzheimer’s treatment. Hospital infusions take an hour each. 2025 is looking to see a new 15-second autoinjector version. For some, it should even work at home.

Can Alzheimer’s Be Treated with Iron-Modifying Drugs?

February 15, 2026

Dietary iron is an essential element in the brain. That’s why it is critical to understand how it affects Alzheimer’s. Researchers used advanced X-ray techniques to take a giant step forward in understanding iron chemistry in amyloid plaque, the main culprit behind Alzheimer’s. Learn more about their exciting new insights.

couple, seniors, happy, smile, elderly, portrait, man, woman, african american, couple, couple, couple, couple, couple, seniors, seniors, elderly, elderly, elderly, african american, african american

I Will Remind You

February 15, 2026

A deep promise to be there for an Alzheimer’s parent, this heartwarming song was written as a tribute to families facing dementia.

14 Ways to Prevent Falling at Home

February 14, 2026

EMERGENCIES due to falling happen 54% more often in dementia. As a rule, 1-in-3 adults over 65 fall each year. Most falls happen at home. Make a few simple changes and prevent falls.

Most Popular Stories

My Forgetfulness: Alzheimer’s or Normal Aging?

People worry about becoming forgetful. Is it the first sign of Alzheimer’s or just the passing years? After all, forgetfulness is a normal part of aging. Check out these quick ways to tell the difference.

Financial Problems Can Signal Dementia Onset

Researchers found in a study that people who developed dementia were more likely to have their credit rating drop at least two and a half years before the diagnosis. Some had problems managing their money up to six years before. Find out more.

Curing Alzheimer’s by Fixing Proteins, Not Clearing Them

Scientists say restoring a brain protein, not removing amyloid plaques, should be the target of Alzheimer’s dementia therapies. The researchers said treatment might lie in normalizing the levels of a specific brain protein.